Measure | Concordant conditions | Discordant conditions | ||
Diabetes with comorbid hypertension | Diabetes with comorbid hypertension and chronic ischaemic heart disease | Diabetes with comorbid osteoarthritis | Diabetes with comorbid osteoarthritis and major depression | |
Process measures | ||||
HbA1c testing | ✓ | ✓ | ✓ | ✓ |
Eye examination | ✓ | ✓ | ✓ | ✓ |
Use of oral hypoglycaemic drugs | ✓ | ✓ | ✓ | ✓ |
Use of ACE inhibitors | ✓ | ✓ | ||
Use of angiotensin II receptor blockers | ✓ | ✓ | ||
Use of antiplatelet drugs | ✓ | |||
Use of statins | ✓ | |||
Use of NSAIDs – * ‘negative’ indicator | ✓ | ✓ | ||
Use of tetracyclic antidepressant – ’negative indicator’ | ✓ | |||
Use of monoamine oxidase inhibitors – ‘negative indicator’ | ✓ | |||
Use of benzodiazepines – ‘negative indicator’ | ✓ | |||
Use of gaba receptor agonists – ’negative indicator’ | ✓ |
*’Negative’ indicators related to contraindicated processes because they increase the risk of adverse outcomes.
HbA1c, glycated haemoglobin; NSAIDs, non-steroidal anti-inflammatory drugs.